Skip to main content
Home
  • The Legislative Assembly meets on 16/04/2024 (01:00 PM)
    Assembly sit 16/04/2024
  • The Legislative Council meets on 16/04/2024 (01:00 PM)
    Council sit 16/04/2024
  • The Public Administration meets on 08/04/2024 (10:00 AM)
    Committee meet 08/04/2024

Parliamentary Questions


Question Without Notice No. 132 asked in the Legislative Council on 25 May 2021 by Hon Nick Goiran

Parliament: 41 Session: 1

CHILD AND ADOLESCENT HEALTH SERVICE — AISHWARYA ASWATH

132. Hon NICK GOIRAN to the minister representing the Minister for Health:

I refer to section 3, ''Work Environment/Scheduling'', of the SAC 1 clinical incident investigation report into the contributing factors and root causes into Aishwarya Aswath's death. When considering work environment/scheduling, the report states ''senior clinicians had escalated substantial concerns around patient safety to senior management'' in October 2020.

(1) Will the minister table the presentation or report made by senior clinicians during this meeting?

(2) If no to (1), why not?

(3) Have any systems, procedures or similar steps been put in place since Aishwarya's death to address the culture that has developed in the hospital that saw escalation as ''futile and ineffective''?

(4) If yes to (3), what are they and will the minister table the documents that verify these changes?

(5) If no to (3), why has nothing been done?

Hon STEPHEN DAWSON replied:

I thank the honourable member for some notice of the question. The following answer is provided on behalf of the Minister for Health.

(1)–(2) The Child and Adolescent Health Service is unable to identify a presentation or report given at a meeting in October 2020.

(3) Yes.

(4) An implementation oversight committee has been established and will meet weekly to oversee implementation of the SAC 1 recommendations and other initiatives across the hospital. Terms of reference are currently being finalised. This provides a specific mechanism for escalation of concerns in addition to routine reporting of safety and quality metrics through the formal clinical governance committee structure.

(5) Not applicable.